🧬 BioMed Pulse · 2026-10-24 02:01 UTC
BIOMED PULSE
October 24, 2026 | Daily Briefing on Longevity, Viruses & New Cures
⚡ TL;DR
The Bundibugyo virus Ebola outbreak in DRC has now spread to Kenya AND Nigeria, marking a dangerous new phase of international spread across Africa. The overall mood is urgent: multiple concurrent outbreaks worldwide, a mysterious pneumonia death in Russia, and MERS cases in Saudi Arabia demand close attention.
🦠 OUTBREAKS & VIRUSES
BUNDIBUGYO EBOLA (DRC, KENYA, NIGERIA) - CRITICAL ESCALATION
- As of October 23, 2026, WHO DON622 confirms the BVD outbreak has expanded to Kenya and Nigeria via imported cases, alongside sustained high-level transmission in DRC. [1]
- The DRC outbreak originated in Mongbwalu health zone, Ituri Province in May 2026 and has since spread across 6 provinces: Bas-Uele, Haut-Uele, Ituri, North Kivu, South Kivu, and Tshopo. [2]
- As of mid-July 2026, cumulative confirmed cases in DRC alone had reached 2,124 with 828 deaths; earlier DONs show the trajectory has continued rising sharply since. [3]
- WHO described this as the largest Ebola outbreak ever reported in DRC, expanding faster than any previous Ebola outbreak. [4]
- An imported case in Kenya was laboratory-confirmed on October 5, 2026, with the patient having traveled from DRC through Uganda. [5]
- Cross-border transmission to Uganda was identified early, with Nigeria now also reporting imported cases as of the October 23 DON. [1]
- WHO first mobilized international Ebola response on May 17, 2026; CDC activated airport screening at Washington-Dulles and Atlanta in late May. [6] [7] [8]
PNEUMONIA OF UNDETERMINED ETIOLOGY - RUSSIA
- On October 2, 2026, WHO was notified through media reports of the death of a researcher at the Irkutsk Antiplague Research Institute of Siberia and the Far East following severe pneumonia. [9]
- The individual worked at a biosafety-relevant facility; WHO is monitoring the situation closely under DON620. [9]
MERS-COV - SAUDI ARABIA
- Between January 1 and October 5, 2026, Saudi Arabia reported 8 laboratory-confirmed MERS-CoV cases including 1 death, detected across 6 locations including Riyadh, Al Jouf, Arar, Hafr Al-Batin, Tabuk, and one additional site. [10]
- MERS-CoV (Middle East Respiratory Syndrome Coronavirus) is a zoonotic virus linked to dromedary camels; person-to-person spread remains limited but healthcare settings carry elevated risk. [10]
ANDES HANTAVIRUS - M/V HONDIUS CRUISE SHIP
- WHO DON611 (July 2, 2026) marked the fifth Disease Outbreak News update on the Andes hantavirus outbreak first notified May 2, 2026 from the cruise ship M/V Hondius, involving severe acute respiratory illness cases onboard.
- Andes hantavirus (ANDV) is notable as the only hantavirus strain with documented person-to-person transmission; CDC provided weekly response transcripts through late June 2026.
NIPAH VIRUS - INDIA
- On June 11, 2026, Kerala State Health Department confirmed one laboratory case of Nipah virus infection in Kozhikode district; the adult male developed neurological symptoms and was hospitalized on June 10.
- Nipah (NiV) carries a case fatality rate of up to 75% and has no approved vaccine; fruit bats are the primary reservoir in South Asia.
YELLOW FEVER - GLOBAL Americas/AFRICA
- WHO DON610 reports that from January 1 to May 26, 2026, six countries reported 79 human yellow fever infections; transmission that increased in the Americas in 2025 carried into 2026.
RABIES - UNITED STATES
- CDC issued a statement on September 10, 2026 noting increases in animal rabies activity and associated human exposures, urging public vigilance.
DRUG-RESISTANT BACTERIA - UNITED STATES
- A September 2025 CDC report documented a dramatic increase in dangerous drug-resistant bacteria (specific species not detailed in the summary), raising antimicrobial resistance alarms.
🧬 LONGEVITY & AGING
NEURONAL SENESCENCE AND SPINAL CORD INJURY
- A Europe PMC study (Genes Dis, July 2026) found that the transcription factor Glis1 alleviates neuronal senescence following spinal cord injury by promoting H3K18 lactylation, a histone modification that reprograms metabolic programming in injured neurons.
- H3K18 lactylation is a relatively newly characterized epigenetic mark linking cell metabolism (lactate production) to gene expression changes that may slow cell aging after injury.
SENESCENT CELLS AND INTERVERTEBRAL DISC DEGENERATION
- A Bioact Mater paper (October 2026) describes a strategy targeting NOX4-associated "ferro-aging," a form of senescence driven by iron accumulation, using an iron-chelating therapy that specifically targets senescent cells in degenerating intervertebral discs.
- The approach directly links ferroptosis biology to tissue aging and offers a potential drug-free therapeutic avenue for disc degeneration in older adults.
mTORC1 INHIBITION FOR DISC DEGENERATION
- A separate Bioact Mater study (October 2026) used cationized gelatin nanospheres to deliver RNA interference targeting mTORC1, a central regulator of cellular aging and autophagy, into intervertebral disc cells, showing protective effects against disc degeneration.
- mTORC1 suppression is one of the best-validated longevity pathways in model organisms; this study applies it to a common age-related musculoskeletal disease.
AI FACE-BASED BIOLOGICAL AGE ESTIMATION
- A Lancet Digital Health study (publication date shown as 2027 but indexed now) developed FAHR-Face, a foundation AI model that estimates biological age from face photographs, validated across multiple cohorts; authors include Gladyshev VN (Harvard) and Aerts HJ, Mak RH.
- The model could enable low-cost, non-invasive biological age screening in clinical and research settings.
BONE AND CARTILAGE REGENERATION IN AGING TISSUE
- A Biomaterials study (August 2026) used single-cell transcriptomics to design a cascade-responsive hydrogel with a bioinspired nanocellular pacemaker specifically targeting aged bone regeneration, accounting for age-related changes in cellular microenvironments.
- A Bioact Mater paper (October 2026) described a DNA-adsorbing nanozyme hydrogel that reprograms the immune-oxidative microenvironment to support stem cell-based cartilage repair in osteoarthritis, a leading age-related joint disease.
OSTEOPOROTIC BONE DEFECT REPAIR
- A Bioact Mater study (August 2026) combined quercetin-derived carbon dots with ZIF-8 nanoparticles and M2 macrophage-derived migrasomes in a microenvironment-responsive hydrogel to enhance regeneration of osteoporotic bone defects, targeting the inflammatory aging microenvironment.
- Quercetin is a plant flavonoid with known senolytic properties; this study embeds it structurally into a biomaterial scaffold rather than delivering it systemically.
ALZHEIMER'S DISEASE COHORT STUDY - CHINA
- The Fuzhou Aging Brain Health Initiative (ClinicalTrials NCT07891429, registered October 2026) is a new observational study in Fujian Province, China, aimed at characterizing pathophysiological patterns and evolutionary trajectories of Alzheimer's disease in older adults.
AGING AND FITNESS LONGITUDINAL STUDY - CHINA
- The China Healthy Aging and Fitness Longitudinal Study (CHALF, NCT07881094) plans to recruit approximately 8,900 older adults nationwide to investigate how physical activity and fitness relate to aging outcomes.
💊 NEW CURES & APPROVALS
HIBSAGO (BEPIROVIRSEN) - GLAXOSMITHKLINE
- GlaxoSmithKline LLC received an original approval (ORIG AP, NDA221276) for HIBSAGO, containing the active ingredient bepirovirsen, an antisense oligonucleotide targeting hepatitis B virus RNA to suppress viral replication and potentially achieve functional cure.
- Bepirovirsen works by binding to all hepatitis B virus mRNA transcripts, blocking production of all viral proteins including surface antigen (HBsAg), a key barrier to functional cure.
JEMPERLI (DOSTARLIMAB-GXLY) - GLAXOSMITHKLINE
- GlaxoSmithKline received a supplemental approval (SUPPL AP, BLA761174) for Jemperli (dostarlimab-gxly), a PD-1 blocking antibody used in gynecological and other solid tumor indications.
- Dostarlimab is a checkpoint inhibitor that releases immune brakes on T cells, enabling them to attack cancer cells expressing PD-L1.
REBLOZYL (LUSPATERCEPT-AAMT) - CELGENE CORP
- Celgene Corp received a supplemental approval (SUPPL AP, BLA761136) for Reblozyl (luspatercept-aamt), an erythroid maturation agent used for anemia in myelodysplastic syndromes and beta-thalassemia.
- Luspatercept works by binding TGF-beta superfamily ligands to reduce signaling that blocks late-stage red blood cell maturation.
TOFACITINIB CITRATE GENERIC - AJANTA PHARMA
- Ajanta Pharma Ltd received an original generic approval (ORIG AP, ANDA219542) for tofacitinib citrate, a JAK1/JAK3 inhibitor indicated for rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and juvenile idiopathic arthritis.
ESTRADIOL AND LEVONORGESTREL - ZYDUS PHARMS
- Zydus Pharms received an original generic approval (ORIG AP, ANDA220407) for an estradiol and levonorgestrel combination product, used in hormone therapy.
APIXABAN GENERIC - TEVA PHARMACEUTICALS USA
- Teva Pharmaceuticals USA Inc received an original tentative approval (ORIG TA, ANDA210142) for apixaban, a Factor Xa inhibitor anticoagulant indicated for stroke prevention in atrial fibrillation and treatment of venous thromboembolism.
🧪 CLINICAL TRIALS
ALZHEIMER DISEASE BRAIN IMAGING COHORT - FUZHOU, CHINA
- NCT07891429 (Fuzhou Aging Brain Health Initiative, registered October 23, 2026): observational study to establish AD cohorts in Fujian Province, China, focusing on biomarker and imaging characterization of disease progression in older adults.
PERSONALIZED TMS FOR COGNITIVE IMPAIRMENT - CEREBRAL SMALL VESSEL DISEASE
- NCT07891650 (registered October 23, 2026): a trial enrolling 160 adults to evaluate personalized intermittent theta burst stimulation (iTBS), a non-invasive transcranial magnetic stimulation protocol, for cognitive impairment caused by cerebral small vessel disease, a major driver of vascular dementia.
IMMERSIVE VR FOR COGNITIVE FUNCTION IN METABOLIC SYNDROME
- NCT07040748: evaluates Virtual-METS, a multimodal immersive virtual reality intervention combining cognitive training and physical exercise, for improving cognitive function in middle-aged adults with metabolic syndrome and subjective cognitive complaints.
CHINA HEALTHY AGING AND FITNESS LONGITUDINAL STUDY
- NCT07881094 (CHALF, registered October 23, 2026): nationwide prospective study targeting approximately 8,900 older adults in China to assess associations between physical fitness and healthy aging trajectories.
NEOANTIGEN T CELL THERAPY FOR HEMATOLOGIC MALIGNANCIES
- NCT06904066: tests autologous T cells transduced with retroviral vectors expressing T cell receptors targeting patient-specific neoepitopes arising from TP53 or RAS mutations in leukemias, a personalized immunotherapy approach for hard-to-treat blood cancers.
BASE-EDITED STEM CELL THERAPY FOR WHIM SYNDROME
- NCT07775313: evaluates hematopoietic stem and progenitor cell gene therapy using base editing to correct CXCR4 mutations causing WHIM syndrome (warts, hypogammaglobulinemia, infections, and myelokathexis), a rare immune deficiency.
MOSAIC HEXAVALENT INFLUENZA VACCINE WITH ALFQ ADJUVANT
- NCT06863142: phase 1 dose-escalation trial of FluMos-v2, an experimental mosaic hexavalent influenza vaccine, with and without the ALFQ adjuvant, in healthy adults; tests broader cross-strain flu protection.
INTRANASAL COVID-19 VACCINE OCU500
- NCT07536308: phase 1 open-label dose-escalation trial of OCU500, a ChAd36 adenoviral vector encoding the SARS-CoV-2 spike protein delivered intranasally and by inhalation, in previously vaccinated adults aged 18-64.
📢 PUBLIC HEALTH
LISTERIA OUTBREAK - PREPARED MEALS (ONGOING)
- As of October 30, 2025 (most recent CDC update in dataset), CDC continued to urge consumers to check refrigerators and freezers for recalled prepared meal products despite prior recalls, as illnesses persisted.
- Earlier updates through September 2025 recorded at least 3 additional illnesses and 1 additional death in the expanding Listeria outbreak linked to prepared foods.
SALMONELLA - MORINGA LEAF SUPPLEMENTS
- An extensively drug-resistant Salmonella outbreak linked to moringa powder capsules resulted in 3 hospitalizations as of February 2026; as of January 29, 2026, a total of 65 people across 28 states had been sickened.
INFANT BOTULISM - NARA ORGANICS FORMULA
- CDC urged parents to immediately stop using Nara Organics Whole Milk Organic Infant Formula following an infant botulism outbreak investigation update on June 13, 2026.
WEST NILE VIRUS - EARLY SEASON SURGE
- CDC reported record early-season West Nile virus cases as of July 1, 2026, urging Americans to use mosquito repellent and avoid outdoor exposure during dawn and dusk hours.
SYPHILIS IN NEWBORNS
- New CDC data (September 2024) showed U.S. congenital syphilis cases increased for the 12th consecutive year in 2024, signaling a persistent public health failure in prenatal STI screening.
U.S. WHO WITHDRAWAL COMPLETED
- The United States formally completed its withdrawal from WHO on January 22, 2026; WHO stated January 24, 2026 that the decision makes both the U.S. and the world less safe.
CANCER MORTALITY PROGRESS
- The 2026 Annual Report to the Nation found that progress against lung cancer is driving down overall U.S. cancer mortality rates, a positive trend credited to smoking cessation and improved targeted therapies.
BIOMED PULSE is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personal health decisions.
📎 Sources
- Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
- Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
- Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
- Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
- Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
- CDC Mobilizes International Response Following Ebola Disease O… — CDC Newsroom
- Enhanced Ebola Airport Screening Begins at Washington-Dulles I… — CDC Newsroom
- Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
- Pneumonia of undetermined etiology - the Russian Federation — WHO Disease Outbreak News
- Middle East respiratory syndrome coronavirus - Kingdom of Saud… — WHO Disease Outbreak News
Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20261024-02-v115 · 2026-10-24 02:01 UTC · pulse.uzylab.com